< Back to latest news & events

News

Ed Sheeran successfully defends hit song ‘Shape Of You’ against High Court copyright infringement claim

April 2022

The UK musician, Ed Sheeran, one of the world’s best selling artists with sales of 26 million albums and 100 million singles worldwide, has successfully defended a claim brought against him for copyright infringement.

In 2017, Ed Sheeran released the song ‘Shape of You’, which is one of the most streamed songs on Spotify with over 3 billion streams. The musician Sam Chokri (who performs under the name Sami Switch) and song writer, Ross O’Donoghue, wrote to Sheeran, claiming that elements of ‘Shape of You’ were stolen from Chokri’s 2015 song ‘Oh Why’, and that the ‘hook’ from Shape of You was “strikingly similar” to a section from Oh Why.

Initially Sheeran applied to the court for a non-infringement declaration. Chokri and O’Donoghue then counterclaimed with a claim for copyright infringement.

Sheeran denied that he had copied the song, and refuted allegations by Chokri’s barrister, Andrew Sutcliffe QC that he was a “magpie” who has copied songs from other artists on numerous other occasions.

Judgment

Mr Justice Zacaroli, handing down his judgment on 6th April 2022, found that although there were similarities between the songs, this did not prove copyright infringement and that arguments that Sheeran had heard Chokri’s song before writing ‘Shape of You’ were only speculative.

In reaching his verdict, Justice Zacaroli stated;

  • Coincidences in songwriting are not uncommon and that the ‘the evidence of similarities and access [was] insufficient to shift the evidential burden so far as deliberate copying is concerned to [Sheeran]
  • Even if the evidential burden had shifted to Sheeran and the other co-claimants, it had been established that Mr Sheeran did not deliberately or subconsciously copy the phrase in his song from the hook in Chokri’s song

Zacaroli also noted the following in relation to the phrasing used on the songs;

“The two phrases play very different roles in their respective songs. The OW Hook (in ‘Oh Why’) is the central part of the song and reflects the song’s slow, brooding and questioning mood. The use of the first four notes of the rising minor pentatonic scale for the melody is so short, simple, commonplace and obvious in the context of the rest of the song that it is not credible that Mr Sheeran sought out inspiration from other songs to come up with it.”

Evidence of copying

In a copyright infringement case, a copyright owner must also prove that the defendant had heard the original work, in order to be able to successfully prove copying, and therefore the fact that copyright infringement has taken place. Although Chokri’s song was widely available, and Mr Chokri argued that he moved in similar circles to Ed Sheeran in the UK music scene and that he had sent his song to people closely associated with Ed Sheeran, he could not produce clear evidence that Sheeran had heard his song before writing ‘Shape of You’.

Lessons for businesses and individuals

An important lesson from this case is that businesses and individuals should document their creative or product development procedures, ensuring that copies of design documents are dated and kept safe, emails are archived and any agreements with third parties working on matters such as consultants are carefully stored away.

This is to ensure that, should a claim for infringement of an intellectual property right such as copyright be brought against yourself or your company, you can prove where an idea originated from and you can demonstrate the process through which this is created in order to refute any such arguments.

As an example of this in practice, following the case discussed above, Ed Sheeran has stated that he now films all of his songwriting sessions, in order to protect against future claims. Documenting any work in this way may save a great deal of time and costs in responding to any potential litigation that may arise in future.


This article was prepared by HGF Senior IP Solicitor Chris Robinson.

Latest updates

Seminar on Incorporating Trade Secrets into your IP Strategy

HGF is hosting a Seminar on Incorporating Trade Secrets into your IP Strategy which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 10th …

Read article

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

Quinas Technology Wins WIPO Global Award for Innovation in ICT

Our client, Quinas Technology, has been named the winner of the WIPO Global Award 2025 in the ICT Startup category. Quinas is a spin-out from Lancaster University. We have worked …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article

Briefing Note: UKIPO SEP Consultation

Overview and Strategic Context The UKIPO’s 2025 consultation on Standard Essential Patents (SEPs), announced on 15 July 2025, signals a potential policy shift in how the UK approaches SEP licensing …

Read article

HGF recognised in Managing IP’s New “Trusted Talent” Table in Germany

We are proud to announce that HGF has been ranked in Managing IP’s newly launched Trusted Talent table in Germany, a recognition of our ongoing commitment to excellence in intellectual …

Read article

ICELAND left out in the cold by the General Court

Earlier in the month, the EU General Court issued its decision on Iceland Foods Ltd’s appeal of a decision of the Grand Board of Appeal of EUIPO to invalidate an …

Read article

A leading case - beware sequence errors in patent claims

Samsung Bioepis UK Ltd v Alexion Pharmaceuticals Inc [2025] EWHC 1240 (Pat) – Mr Justice Meade – 20 May 2025 The UK Patents Court has held that Samsung Bioepis’ and Amgen’s …

Read article